The Max von Pettenkofer Institute of Ludwig Maximilian University of Munich (LMU) has been appointed German National Reference Centre for Retroviruses. With this, it assumes central networking tasks
The bacterium Helicobacter pylori is an important gut pathogen and the main cause of gastric ulcers and gastric cancer. As yet it was not clear, which mechanisms play a role in these secondary
Multidrug-resistant tuberculosis is continuously spreading. Treatment has many side effects, is costly and, above all, lengthy. Since May 2016, the World Health Organisation (WHO) has recommended a
Epstein-Barr virus (EBV) prevents infected cells from being attacked by the immune system. The virus drives production of small molecules, so-called microRNAs, that suppress alarm signals sent out by
Some HIV-infected – and untreated children – who do not develop AIDS, control the virus in a different way from the few infected adults who remain disease-free. Scientists at LMU´s Max von Pettenkofer
The European Research Council (ERC) awarded Dr Alexander Titz, who is the head of the "Chemical Biology of Carbohydrates" junior research group of the Helmholtz Centre for Infection Research (HZI) and
The German Center for Infection Research (DZIF) is one of nine founding organisations that have launched the alliance “CARA” (Conscience of Antimicrobial Resistance Accountability). Today, a
In chronic hepatitis B patients, a discontinuation of treatment can lead to cure: as scientists from the Hannover Medical School (MHH) have discovered. DZIF researcher Prof Markus Cornberg and his
Over a period of five years, an international team of scientists has documented in detail the treatment success of patients with severe tuberculosis. During this period, the team also reviewed the
The Heidelberg virologist Prof Ralf Bartenschlager will receive the Lasker Award in New York for his research on the hepatitis C virus. The prize, worth 250,000 US dollars, is considered the
